Croucher PI - Search Results

1

Metastasis and bone loss: advancing treatment and prevention.

Coleman RE, Lipton A, Roodman GD, Guise TA, Boyce BF, Brufsky AM, Clézardin P, Croucher PI, Gralow JR, Hadji P, Holen I, Mundy GR, Smith MR, Suva LJ. Coleman RE, et al. Among authors: croucher pi. Cancer Treat Rev. 2010 Dec;36(8):615-20. doi: 10.1016/j.ctrv.2010.04.003. Epub 2010 May 15. Cancer Treat Rev. 2010. PMID: 20478658 Free PMC article. Review.

2

The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel.

Jagdev SP, Coleman RE, Shipman CM, Rostami-H A, Croucher PI. Jagdev SP, et al. Among authors: croucher pi. Br J Cancer. 2001 Apr 20;84(8):1126-34. doi: 10.1054/bjoc.2001.1727. Br J Cancer. 2001. PMID: 11308265 Free PMC article.

3

Evidence of a role for a non-matrix-type metalloproteinase activity in the shedding of syndecan-1 from human myeloma cells.

Holen I, Drury NL, Hargreaves PG, Croucher PI. Holen I, et al. Among authors: croucher pi. Br J Haematol. 2001 Aug;114(2):414-21. doi: 10.1046/j.1365-2141.2001.02963.x. Br J Haematol. 2001. PMID: 11529866 Free article.

4

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.

Holen I, Croucher PI, Hamdy FC, Eaton CL. Holen I, et al. Among authors: croucher pi. Cancer Res. 2002 Mar 15;62(6):1619-23. Cancer Res. 2002. PMID: 11912131

5

The anti-tumor potential of zoledronic acid.

Croucher P, Jagdev S, Coleman R. Croucher P, et al. Breast. 2003 Aug;12 Suppl 2:S30-6. doi: 10.1016/s0960-9776(03)80161-3. Breast. 2003. PMID: 14659141 Review.

6

Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.

Eaton CL, Wells JM, Holen I, Croucher PI, Hamdy FC. Eaton CL, et al. Among authors: croucher pi. Prostate. 2004 May 15;59(3):304-10. doi: 10.1002/pros.20016. Prostate. 2004. PMID: 15042606

7

Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo--a role in tumour cell survival?

Holen I, Cross SS, Neville-Webbe HL, Cross NA, Balasubramanian SP, Croucher PI, Evans CA, Lippitt JM, Coleman RE, Eaton CL. Holen I, et al. Among authors: croucher pi. Breast Cancer Res Treat. 2005 Aug;92(3):207-15. doi: 10.1007/s10549-005-2419-8. Breast Cancer Res Treat. 2005. PMID: 16155791

8

Bisphosphonates in preclinical bone oncology.

Clézardin P, Benzaïd I, Croucher PI. Clézardin P, et al. Among authors: croucher pi. Bone. 2011 Jul;49(1):66-70. doi: 10.1016/j.bone.2010.11.017. Epub 2010 Dec 8. Bone. 2011. PMID: 21145441 Review.

9

Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo.

Ottewell PD, Wang N, Brown HK, Reeves KJ, Fowles CA, Croucher PI, Eaton CL, Holen I. Ottewell PD, et al. Among authors: croucher pi. Clin Cancer Res. 2014 Jun 1;20(11):2922-32. doi: 10.1158/1078-0432.CCR-13-1246. Epub 2014 Mar 31. Clin Cancer Res. 2014. PMID: 24687923 Free PMC article.

10

Prostate cancer cells preferentially home to osteoblast-rich areas in the early stages of bone metastasis: evidence from in vivo models.

Wang N, Docherty FE, Brown HK, Reeves KJ, Fowles AC, Ottewell PD, Dear TN, Holen I, Croucher PI, Eaton CL. Wang N, et al. Among authors: croucher pi. J Bone Miner Res. 2014 Dec;29(12):2688-96. doi: 10.1002/jbmr.2300. J Bone Miner Res. 2014. PMID: 24956445 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page